MEDICAL

Neurologic Complications of HIV Disease

Neurologic Complications Volume 27 Issue 1 April 2019

HIV is Associated with Lung Function Impairment in the Multicenter AIDS Cohort Study

NATAP | April 28, 2019

DAA therapy for HCV lowers risk of cardiovascular disease at all fibrosis stages

Conference on Retroviruses and Opportunistic Infections (CROI), March 4-7, 2019, Seattle

High endothelial dysfunction rate with recent HIV in young adults with low cardiovascular risk

Conference on Retroviruses and Opportunistic Infections (CROI), March 4-7, 2019, Seattle

"Impact of PrEP on drug resistance and acute HIV infection, New York City, 2015-2017”

CROI 2019 March 4-7 Seattle

PML-IRIS ensuing CNS and subsequent peripheral viral escape of ARV-resistant variants

CROI 2019 March 4-7 Seattle

Neurosymptomatic HIV-1 CSF Escape can Occur with Replication in CD4+ T Cells in the CNS

CROI 2019 March 4-7 Seattle

Rebound Of HIV-1 In Cerebrospinal Fluid (CSF) After Treatment Interruption (TI)

CROI 2019 March 4-7 Seattle

New fracture independently boosts death risk in big US HIV cohort

CROI 2019 March 4-7 Seattle

Up to 95% virologic response rate with rapid ART in safety-net clinic

CROI 2019 March 4-7 Seattle

Estimate of US MSM eligible for PrEP jumps from 25% in 2015 to 45% today

CROI 2019 March 4-7 Seattle

In utero HIV exposure tied to obesity, reactive airway disease in adolescence

CROI 2019 March 4-7 Seattle

High maternal HBV with HIV tied to low infant weight and HIV transmission

CROI 2019 March 4-7 Seattle

Second patient free of HIV after stem-cell therapy

CROI March 4-7  Seattle

Researchers report high rate of viral suppression among people new to HIV care

NIH | 03/07/2019 05:30 PM EST

When Undetectable Is Unachievable: Study Offers Insights into HIV Persistence

HIV.gov | March 5, 2019

Injecting drugs, HCV, race are syphilis risk factors in US women with HIV

CROI 2019 March 4-7 Seattle

Obesity--but not frailty--predicts neurocognitive impairment with HIV

CROI 2019 March 4-7 Seattle

Duration of infectiousness among persons with HIV diagnosed during 2012-2016

CROI March 4-7  Seattle

One in 50 in NYC with recently diagnosed HIV used PrEP in preceding months

CROI 2019 March 4-7 Seattle

Higher HIV load, lower CD4s predict liver cancer without advanced fibrosis

CROI 2019 March 4-7 Seattle

More than 1 year to HIV control raises failure risk almost 10-fold

CROI 2019 March 4-7 Seattle

COPD doubles heart attack risk with HIV regardless of smoking

CROI 2019 March 4-7 Seattle

Longer sustained use of levonorgestrel IUD than copper IUD by women with HIV

CROI 2019 March 4-7 Seattle

Higher risk of recurrent venous thromboembolism with HIV in Dutch national study

CROI 2019 March 4-7 Seattle

Successful HCV treatment does not affect rate of heart disease or non-AIDS cancer

CROI 2019 March 4-7 Seattle

Successful HCV treatment does not affect rate of heart disease or non-AIDS cancer

CROI 2019 March 4-7 Seattle

Clinical Outcomes in Persons Coinfected with HIV and HCV: Impact of HCV Treatment

CROI 2019 March 4-7 Seattle

Breaking Bones is Bad: Incident Fracture and Mortality in the HIV Outpatient Study

CROI 2019 March 4-7 Seattle

Sudden cardiac death risk higher with HIV--but not with sustained HIV control /  “Sudden cardiac death among HIV-infected and -uninfected veterans”

CROI 2019 March 4-7 Seattle

More new lung cancer in women than men with HIV--standard screening inadequate -  " Optimal lung cancer screening criteria among persons living with HIV"

CROI 2019 March 4-7 Seattle

   
HIV.GOV

HIV "Cure" Update and More: Research Highlights from CROI 2019 (video)

CROI 2019 March 4-7 Seattle

HIV Research Update and Preview of CROI 2019 from NIH’s Dr. Carl Dieffenbach (video)

CROI 2019 March 4-7 Seattle

Final Updates from HIV.gov at This Week's Conference on Retroviruses and Opportunistic Infections

CROI 2019 March 4-7 Seattle

   
MEDICATION

CROI: SAFETY AND PK OF SUBCUTANEOUS GS-6207, A NOVEL HIV-1 CAPSID INHIBITOR

NATAP | March 07, 2019

AIDS illness, living in US South, lower CD4s linked to longer hospital stay with HIV

Conference on Retroviruses and Opportunistic Infections (CROI), March 4-7, 2019, Seattle

Little or no weight gain with long-acting injectable cabotegravir for PrEP

CROI 2019 March 4-7 Seattle

MK-8591 Potency and PK Provide High Inhibitory Quotients at Low Doses QD and QW

CROI 2019 March 4-7 Seattle

THERAPEUTIC ACTIVITY OF PGT121 MONOCLONAL ANTIBODY IN HIV-INFECTED ADULTS   

CROI 2019 March 4-7 Seattle

 

A Phase IIa Study of a Novel Maturation Inhibitor GSK2838232 in HIV patients

CROI 2019 March 4-7 Seattle

Therapeutic activity of PGT121 monoclonal antibody in HIV-infected adults

CROI 2019 March 4-7 Seattle

Memory and Learning Dysfunction with Integrase Strand Transfer Inhibitor Use

CROI 2019 March 4-7 Seattle

Monthly injected cabotegravir/rilpivirine noninferior to oral DTG at 48 weeks

CROI 2019 March 4-7 Seattle

Lymphoid tissue PKs of tenofovir-alafenamide vs. -disoproxil fumarate / Tenofovir levels in human PBMCs and lymph nodes higher with TAF than TDF

CROI 2019 March 4-7 Seattle

Antiactivation activity with kinase inhibitor - JAK Inhbitor - added to suppressive ART / "Safety, tolerability and immunologic activity of ruxolitinib added to suppressive ART"

CROI 2019 March 4-7 Seattle

Better HIV control with dolutegravir than efavirenz started late in pregnancy / “RCT of dolutegravir vs efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2”    

CROI 2019 March 4-7 Seattle

   
HIV & AGING

Frequent PSA screening, lower prostate cancer incidence, in veterans with HIV

CROI 2019 March 4-7 Seattle

One third of elderly HIV group takes complex regimens and risks drug interactions

CROI 2019 March 4-7 Seattle

Two thirds of HIV group report pain and 14% endure "widespread” pain….[50% to 80% report pain, average age only 53]

CROI 2019 March 4-7 Seattle

   
MENTAL HEALTH

Yearly suicide rate in white men with HIV usually far exceeds rate in US population

CROI 2019 March 4-7 Seattle

Cognitive impairment tied to doubled death risk in US and African HIV groups

Conference on Retroviruses and Opportunistic Infections (CROI), March 4-7, 2019, Seattle

   
NEWS COVERAGE
CROI 2019 Webcast Sessions
NAM/aidsmap Coverage
Science Speaks from IDSA Global Health Coverage